RxDoctor Payments Data

Isaiah Brown, MD

Vascular Surgery · Sun City, AZNPI 1003235102

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (46.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Medtronic at 54.7% of the total. Reporting peaked in 2020 at $10,269 and has fallen 65.9% since, to $3,499 in 2025.

$21,542in general payments, 2019–2025

Across 129 payments — averaging $166.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$12K
  • Angiodynamics, Inc.$3K
  • Penumbra, Inc.$3K
  • Endologix LLC$2K
  • W. L. Gore & Associates, Inc.$771
  • Inari Medical, Inc.$255
  • plus $567 from 9 others

What the payments were for

  • Grants$10,00046%
  • Travel & lodging$2,31511%
  • Food & beverage$6,54230%
  • Education$4072%
  • Other$2,27811%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,542 in reported general payments places this provider in the 75th percentile of 105 vascular surgery providers in Arizona.

See all vascular surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$215,733
Medicare patients
267
Services billed
868

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$10,282
Cilostazol12$427
ClopidogrelClopidogrel Bisulfate28$319
Oxycodone Hcl23$115

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Sun City

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →